U.S. Approves Lung Cancer Drug Priced at $780,000
The U.S. has recently approved the drug tarlatamab-dlle for the treatment of metastatic small cell lung cancer, priced at $780,000 for one year of treatment.The decision was made by the ...
The U.S. has recently approved the drug tarlatamab-dlle for the treatment of metastatic small cell lung cancer, priced at $780,000 for one year of treatment.The decision was made by the ...
At Scimyst, we uncover the wonders of science, history, and culture. From ancient mysteries to modern innovations, our stories inspire curiosity and connect you to the fascinating world around us. Explore the unknown with us!
© 2025 Scimyst - Your gateway to the wonders of science and culture
© 2025 Scimyst - Your gateway to the wonders of science and culture